ARTHUR E FREYRE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health SAN ANTONIO, TX NPI 1982945879

General Payments — all program years on this page

$651.31

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 29
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $471.83 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $471.8320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $179.489
2024 $471.8320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078214723 Janssen Pharmaceuticals, Inc $21.13 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107132932 ABBVIE INC. $15.95 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107132934 ABBVIE INC. $26.00 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107132936 ABBVIE INC. $15.70 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119074556 Otsuka America Pharmaceutical, Inc. $24.72 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119074558 Otsuka America Pharmaceutical, Inc. $15.56 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133943240 Vanda Pharmaceuticals Inc. $31.00 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133943242 Vanda Pharmaceuticals Inc. $14.21 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133943244 Vanda Pharmaceuticals Inc. $16.46 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133943246 Vanda Pharmaceuticals Inc. $20.54 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143454094 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.29 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143454098 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.21 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143454102 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.52 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147874717 Supernus Pharmaceuticals, Inc. $14.29 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147874719 Supernus Pharmaceuticals, Inc. $23.24 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151556867 Teva Pharmaceuticals USA, Inc. $124.99 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151556909 Teva Pharmaceuticals USA, Inc. $20.91 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151556945 Teva Pharmaceuticals USA, Inc. $3.12 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151556947 Teva Pharmaceuticals USA, Inc. $13.19 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151556971 Teva Pharmaceuticals USA, Inc. $12.80 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.